Sarah Fischer
0000-0002-6722-643X
1 paper found
Refreshing results…
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab
Missing publications? Search for publications with a matching author name.